Predictors of response and course in patients with inflammatory bowel disease treated with biological therapy: The Danish IBD-Biobank project

被引：0
|
作者：
Zhao, M. [1 ]
Bendtsen, F. [1 ]
Petersen, A. M. [1 ,2 ]
Larsen, L. [3 ]
Jess, T. [3 ,4 ]
Dige, A. [5 ]
Hvas, C. [5 ]
Seidelin, J. [6 ]
Burisch, J. [1 ]
机构：
[1] Hvidovre Univ Hosp, Gastro Unit, Div Med, Hvidovre, Denmark
[2] Hvidovre Univ Hosp, Dept Clin Microbiol, Hvidovre, Denmark
[3] Aalborg Univ Hosp, Dept Gastroenterol & Hepatol, Aalborg, Denmark
[4] State Serum Inst, Dept Epidemiol Res, Copenhagen, Denmark
[5] Aarhus Univ Hosp, Dept Gastroenterol & Hepatol, Aarhus, Denmark
[6] Herlev Univ Hosp, Gastro Unit, Med Div, Herlev, Denmark
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P634
引用
收藏
页码：S526 / S527
页数：2
相关论文
共 50 条
  • [1] Predictors of response and disease course in patients with inflammatory bowel disease treated with biological therapy-the Danish IBD Biobank Project: protocol for a multicentre prospective cohort study
    Zhao, Mirabella
    Bendtsen, Flemming
    Petersen, Andreas Munk
    Larsen, Lone
    Dige, Anders
    Hvas, Christian
    Seidelin, Jakob Benedict
    Burisch, Johan
    BMJ OPEN, 2020, 10 (02):
  • [2] MONITORING THE PSYCHOPATHOLOGICAL PROFILE OF INFLAMMATORY BOWEL DISEASE (IBD) PATIENTS TREATED WITH BIOLOGICAL AGENTS
    Balzoni, L. M.
    D'Onofrio, A. M.
    Ferrajoli, G. F.
    Di Vincenzo, F.
    Sani, G.
    Gasbarrini, A.
    Scaldaferri, F.
    Camardese, G.
    DIGESTIVE AND LIVER DISEASE, 2024, 56 : S216 - S216
  • [3] Mechanisms of molecular resistance and predictors of response to biological therapy in inflammatory bowel disease
    Atreya, Raja
    Neurath, Markus F.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (11): : 790 - 802
  • [4] The Danish National Registry for Biological Therapy in Inflammatory Bowel Disease
    Larsen, Lone
    Jensen, Michael Dam
    Larsen, Michael Due
    Nielsen, Rasmus Gaardskaer
    Thorsgaard, Niels
    Vind, Ida
    Wildt, Signe
    Kjeldsen, Jens
    CLINICAL EPIDEMIOLOGY, 2016, 8 : 607 - 612
  • [5] RESCUE TREATMENT WITH TACROLIMUS IN PATIENTS WITH SEVERE INFLAMMATORY BOWEL DISEASE (IBD) WITHOUT RESPONSE TO INTENSIFICATION OF BIOLOGICAL THERAPY
    Sanchis, Laura
    Cortes, Xavier
    Jose Ramon, Moles M.
    Josefa Rodriguez, Maria
    Fernandez, Sergio
    Borras Blasco, Joaquin
    GASTROENTEROLOGY, 2018, 154 (06) : S849 - S849
  • [6] Rescue treatment with tacrolimus in patients with severe inflammatory bowel disease (IBD) without response to intensification of biological therapy
    Sanchis, L.
    Cortes, X.
    Clofent, J.
    Rodriguez, J.
    Moles, J. R.
    Fernandez, S.
    Borras, J.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S501 - S502
  • [7] Cardiac Troponins in Patients Treated with Biological Therapy for Inflammatory Bowel Disease
    Taylor, Kristin M.
    Lawson, Graham
    Harris, Adam
    GASTROENTEROLOGY, 2009, 136 (05) : A656 - A656
  • [8] Markers of the course of inflammatory bowel disease treated with immunomodulators or biological agents
    Gonzalez-Lama, Yago
    Isabel Vera, Maria
    Calvo, Marta
    Abreu, Lluis
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2010, 33 (06): : 449 - 460
  • [9] Osteopenia and osteoporosis in patients with inflammatory bowel disease (IBD): Evaluation by disease type and the response to alendronate therapy
    Deauseault, DL
    Valentine, JF
    GASTROENTEROLOGY, 1999, 116 (04) : A697 - A697
  • [10] Transcriptomics analysis of intestinal biopsies for prediction of therapy response in patients with inflammatory bowel disease (IBD)
    Hikmat, Zainab
    Thomassen, Mads
    Andresen, Trine
    Andersen, Vibeke
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 695 - 696
12345